Zobrazeno 1 - 10
of 196
pro vyhledávání: '"Eugene, R Viscusi"'
Autor:
Eugene R. Viscusi, Richard Langford, Adelaida Morte, Anna Vaqué, Jesús Cebrecos, Mariano Sust, José María Giménez-Arnau, Oscar de Leon-Casasola
Publikováno v:
Pain and Therapy, Vol 13, Iss 6, Pp 1617-1631 (2024)
Abstract Introduction Multi-modal analgesia is desirable for the management of acute pain since it can provide effective pain relief at lower doses, thereby aiding tolerability. Co-crystal of tramadol-celecoxib (CTC) provides effective analgesia in m
Externí odkaz:
https://doaj.org/article/915a54414edb4cf9857235723f72b67d
Publikováno v:
Pain and Therapy, Vol 13, Iss 6, Pp 1351-1376 (2024)
Abstract Acute moderate-to-severe pain is common after surgery, trauma, or musculoskeletal injury, but its management remains suboptimal. Current single-agent treatments are limited by safety concerns, narrow therapeutic windows, and abuse potential,
Externí odkaz:
https://doaj.org/article/af204ad5fd544685acee9839994e078c
Autor:
Richard Langford, Eugene R. Viscusi, Adelaida Morte, Jesús Cebrecos, Mariano Sust, José María Giménez-Arnau, Oscar de Leon-Casasola
Publikováno v:
Drugs in R&D, Vol 24, Iss 2, Pp 239-252 (2024)
Abstract Background and Objectives New acute pain medications are needed that provide effective analgesia while minimizing side effects and opioid exposure. Clinical trials of co-crystal of tramadol-celecoxib (CTC) have demonstrated an improved benef
Externí odkaz:
https://doaj.org/article/19b3c818f9a44197b7fa0da272900cc9
Autor:
Eugene R. Viscusi, Marc C. Torjman, Catherine L. Munera, Joseph W. Stauffer, Beatrice S. Setnik, Sukirti N. Bagal
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 5, Pp 1886-1893 (2021)
Abstract Difelikefalin, a selective kappa opioid receptor agonist designed to limit central nervous system (CNS) penetration, is under development for the treatment of pruritus. Its hydrophilic, small‐peptidic structure limits CNS entry, minimizing
Externí odkaz:
https://doaj.org/article/3b982fee4bb049f88ec64eac8405037b
Autor:
Shalini Shah, Eric S Schwenk, Rakesh V Sondekoppam, Hance Clarke, Mark Zakowski, Rachel S Rzasa-Lynn, Brent Yeung, Kate Nicholson, Gary Schwartz, W Michael Hooten, Mark Wallace, Eugene R Viscusi, Samer Narouze
Publikováno v:
Regional Anesthesia & Pain Medicine. 48:97-117
BackgroundThe past two decades have seen an increase in cannabis use due to both regulatory changes and an interest in potential therapeutic effects of the substance, yet many aspects of the substance and their health implications remain controversia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8359e876dfe63175f308d0512f310c19
https://doi.org/10.1136/rapm-2022-104013
https://doi.org/10.1136/rapm-2022-104013
Autor:
Steven P. Cohen, Eric S. Schwenk, Eugene R. Viscusi, on behalf of the American Society of Regional Anesthesia & Pain Medicine and American Academy of Pain Medicine Ketamine Guidelines Committees
Publikováno v:
PAIN Reports, Vol 4, Iss 3, p e728 (2019)
Externí odkaz:
https://doaj.org/article/1dafb8b00bd849b2b82971654fb52ddc
Autor:
Hsiangkuo Yuan, Aniket Natekar, Jade S. Park, Clinton Lauritsen, Eugene R. Viscusi, Michael J. Marmura
Subanesthetic ketamine infusion has been used for managing refractory headache in inpatient or outpatient infusion settings. Intranasal (IN) ketamine may be an alternative option for outpatient care.We performed a retrospective study at a single tert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::544bc9a2d4377e283f64e4300b2dee8f
https://doi.org/10.1101/2022.11.20.22282558
https://doi.org/10.1101/2022.11.20.22282558
Autor:
Alexander S. McLawhorn, Sang Jo Kim, Jacques T. YaDeau, Christopher L. Wu, Rosemary Hogg, George Go, Ellen M. Soffin, Janis Bekeris, Carlos B. Mantilla, Sandra L. Kopp, Paul Kessler, Peter Gerner, Rebecca L. Johnson, Jiabin Liu, Douglas S Wetmore, Jashvant Poeran, Philip Peng, Rie Goto, Eriphili Argyra, Mary J. Hargett, Pamela Wendel, Nigel E. Sharrock, Crispiana Cozowicz, Patricia Lavand'homme, Lila Baaklini, Effrossyni Gina Votta-Velis, Lazaros Poultsides, Eric C. Sun, Javad Parvizi, Eric S. Schwenk, Lukas Pichler, Michael John Barrington, Catherine H. MacLean, Alain Borgeat, Jose De Andres, Alejandro Gonzalez Della Valle, Stavros G. Memtsoudis, Kariem El-Boghdadly, Nabil M. Elkassabany, Eugene R. Viscusi, Ottokar Stundner, Henrik Kehlet, Philippe Gautier, Bradley H. Lee, Genewoo Hong, Michael L. Parks, Enrique A. Goytizolo, Brian D. Sites, Dan McIsaac, Dace Bekere, Vassilis Athanassoglou, Edward R. Mariano, Joseph M. Neal, Zhenggang Guo, Alan J. R. Macfarlane, Bridget Jivanelli, Mark Brouillette
Publikováno v:
Regional Anesthesia & Pain Medicine. 46:971-985
BackgroundEvidence-based international expert consensus regarding the impact of peripheral nerve block (PNB) use in total hip/knee arthroplasty surgery.MethodsA systematic review and meta-analysis: randomized controlled and observational studies inve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0dff4d7cb5cecc9097f4c5bc116aac0
https://doi.org/10.1136/rapm-2021-102750
https://doi.org/10.1136/rapm-2021-102750
Autor:
Catherine Munera, Eugene R. Viscusi, Beatrice Setnik, Joseph W. Stauffer, Sukirti N. Bagal, Marc C. Torjman
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 14, Iss 5, Pp 1886-1893 (2021)
Clinical and Translational Science, Vol 14, Iss 5, Pp 1886-1893 (2021)
Difelikefalin, a selective kappa opioid receptor agonist designed to limit central nervous system (CNS) penetration, is under development for the treatment of pruritus. Its hydrophilic, small‐peptidic structure limits CNS entry, minimizing potentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c12957dcc80984d4a9573ad40c93c93a
http://europepmc.org/articles/PMC8504812
http://europepmc.org/articles/PMC8504812
Autor:
Hsiangkuo Yuan, Aniket Natekar, Jade Park, Clinton G Lauritsen, Eugene R Viscusi, Michael J Marmura
Publikováno v:
Regional Anesthesia & Pain Medicine. :rapm-2022
IntroductionSubanesthetic ketamine infusion has been used for managing refractory headache in inpatient or outpatient infusion settings. Intranasal ketamine may be an alternative option for outpatient care.MethodsA retrospective study was conducted a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b64ca624b1f52e0f6dd00587c570d4c9
https://doi.org/10.1136/rapm-2022-104223
https://doi.org/10.1136/rapm-2022-104223